NCT-20X
N/A
Report date: 2023/02/19 17:50:43
NME
Base Information
Drug NameNCT-20X
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesNovacell Technology Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNovacell Technology Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A